European Journal of Cancer
Volume 45, Issue 18 , Pages 3172-3181 , December 2009

Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer

  • Christina Gundgaard Pedersen

      Affiliations

    • Psychooncology Research Unit, Aarhus University Hospital and Aarhus University, Denmark
    • Corresponding Author InformationCorresponding author: Address: Psychooncology Research Unit, Aarhus University Hospital and Aarhus University, Jens Chr. Skous Vej 4, 8000 Aarhus C, Denmark. Tel.: +45 89 42 66 27; fax: +45 89 42 66 23.
    • ,
  • Søren Christensen

      Affiliations

    • Psychooncology Research Unit, Aarhus University Hospital and Aarhus University, Denmark
    • ,
  • Anders Bonde Jensen

      Affiliations

    • Department of Oncology, Aarhus University Hospital, Denmark
    • ,
  • Robert Zachariae

      Affiliations

    • Psychooncology Research Unit, Aarhus University Hospital and Aarhus University, Denmark

Received 28 May 2009 ,Revised 14 August 2009 ,Accepted 4 September 2009.

References 

  1. Sparreboom A, Cox M, Acharya M, et al. Herbal remedies in the United States: potential adverse interactions with anticancer drugs. J Clin Oncol. 2004;22(12):2489–2503
  2. Herman PM, Craig BM, Caspi O. Is complementary and alternative medicine (CAM) cost-effective? A systematic review. BMC Complem Altern Med. 2005;5:(11)
  3. Ernst E, Resch K, Mills S. Complementary Medicine – a definition. Brit J Gen Pract. 1995;45:(506)
  4. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer – a systematic review. Cancer. 1998;83(4):777–782
  5. Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16:655–663
  6. Fouladbakhsh J, Stommel M, Given B, et al. Predictors of use of complementary and alternative therapies among patients with cancer. Oncol Nurs Forum. 2005;32(6):1115–1122
  7. Boon H, Olatunde F, Zick M. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health. 2007;7:(4)
  8. Molassiotis A, Scott J, Kearney N, et al. Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer. 2006;14(3):260–267
  9. Damkier A. Cancer patients use of alternative treatment. PhD thesis. Institute of Health, University of Southern Denmark; 2000 [Danish].
  10. Jensen A. The impact of psychological and social factors upon the disease course in breast cancer. PhD thesis. Institute of Health, University of Southern Denmark; 1995 [Danish].
  11. Grønvold M, Pedersen C, Jensen C, Faber M, Johnsen A. The cancer patient’s world – a study on what Danish cancer patients need. Patientstøtteafdelingen, Kræftens Bekæmpelse; 2006 [Danish].
  12. Anker N. Cancer patients use of alternative treatment: a study among users of the Danish Cancer Society’s telephone counselling – the cancer line. Patientstøtteafdelingen, Kræftens Bekæmpelse; 2006 [Danish].
  13. Boon H, Stewart M, Kennard MA, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol. 2000;18(13):2515–2521
  14. Lee M, Lin S, Wrensch R, et al. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst. 2000;92:42–47
  15. Cui Y, Shu X, Gao Y, et al. Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat. 2004;85:263–270
  16. Shen J, Andersen R, Albert P, et al. Use of complementary/alternative therapies by women with advance-stage breast cancer. BMC Complem Altern Med. 2002;2(8):
  17. Patterson R, Neuhouser M, Hedderson M, et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complem Med. 2002;8:477–485
  18. Moschén R, Kemmler G, Schweigkofler H, et al. Use of alternative/complementary therapy in breast cancer patients – a psychological perspective. Support Care Cancer. 2001;9:267–274
  19. Richardson M, Sanders T, Palmer J, et al. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18:2505–2514
  20. Burstein HJ, Gelber S, Guadagnoli E, et al. Use of alternative medicine by women with early-stage breast cancer. New Engl J Med. 1999;340(22):1733–1739
  21. Ashikaga T, Bosompra K, O’Brien P, et al. Use of complementary and alternative medicine by breast cancer patient: prevalence, patterns and communication with physicians. Support Care Cancer. 2002;10:542–548
  22. Johannesen H. Alternative treatment in Europe – prevalence, use, and effect. A literature study. Copenhagen: The National Board of Health on Alternative Therapies; 1995;[Danish]
  23. Verhoef M, Balneaves L, Boon H, et al. Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Therap. 2005;4(4):274–286
  24. Conboy L, Patel S, Kaptchuk T, et al. Sociodemographic determinants of the utilization of specific types of complementary and alternative medicine: an analysis based on a nationally representative survey sample. J Altern Complem Med. 2005;11(6):977–994
  25. Kimby CK, Launso L, Henningsen I, et al. Choice of unconventional treatment by patients with cancer. J Altern Complem Med. 2003;9(4):549–561
  26. Christensen S, Zachariae R, Jensen A, et al. Prevalence and risk of depressive symptoms 3–4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Res Treat. 2009;113(2):339–355
  27. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383
  28. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20(17):3628–3636
  29. Rostgaard K, Holst H, Mouridsen HT, et al. Do clinical databases render population-based cancer registers obsolete? The example of breast cancer in Denmark. Cancer Cause Control. 2000;11(7):669–674
  30. Statistics Denmark. 2005. http://www.dst.dk/HomeUK/About/introSD.aspx, Statistics Denmark.
  31. National Institute of Public Health. Health and morbidity survey 2000. Self-administered questionnaire. Copenhagen: National Institute of Public Health; 2001 [Danish].
  32. Kjøller M, Rasmussen N. Health and morbidity in Denmark 2000 & development since 1987. Copenhagen: National Institute of Public Health; 2002 [Danish].
  33. Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol. 2000;35(3):181–200
  34. Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer. 2000;36(4):453–471
  35. Ware JE, Sherbourne CD. The Mos 36-item short-form health survey (Sf-36). Conceptual-framework and item selection. Med Care. 1992;30(6):473–483
  36. World Health Organization. Obesity. Preventing and managing the global endemic. Technical Report Series No. 894. Geneva, WHO; 2000.
  37. Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Meth. 2002;7(2):147–177
  38. Downer SM, Cody MM, McClusky P, et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ. 1994;309(6947):86–89
  39. Lerner IJ, Kennedy BJ. The prevalence of questionable methods of cancer treatment in the United States. CA Cancer J Clin. 1992;42(3):181–191
  40. Nagel G, Hoyer H, Katenkamp D. Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey. Support Care Cancer. 2004;12(11):789–796
  41. Baider L, Andritsch E, Uziely B, et al. Effects of age on coping and psychological distress in women diagnosed with breast cancer: review of literature and analysis of two different geographical settings. Crit Rev Oncol Hematol. 2003;46:5–16
  42. Bartman J, Roberto K. Coping strategies of middle-aged and older women who have undergone a mastectomy. J Appl Gerontol. 1996;15:376–386
  43. Gozum S, Tezel A, Koc M. Complementary alternative treatments used by patients with cancer in Eastern Turkey. Cancer Nurs. 2003;26:230–236
  44. Lengacher C, Bennet M, Kip K, et al. Relief of symptoms, side effects, and psychological distress through use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum. 2006;33(1):97–100
  45. Henderson JW, Donatelle RJ. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altern Ther Health Med. 2004;10(1):52–57
  46. Rees R, Feigel I, Vickers A, et al. Prevalence of complementary therapy use by women with breast cancer: a population-based survey. Eur J Cancer. 2000;36:1359–1364
  47. Morris K, Johnson N, Homer L, et al. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg. 2000;179:407–411

PII: S0959-8049(09)00677-7

doi: 10.1016/j.ejca.2009.09.005

European Journal of Cancer
Volume 45, Issue 18 , Pages 3172-3181 , December 2009

Article Tools

* Image Usage & Resolution